Related Experiment Video
Updated: Nov 22, 2025

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells
Published on: June 16, 2022
Long non-coding antisense RNA HYOU1-AS is essential to human breast cancer development through competitive binding
Aixin Hao1, Yu Wang1, Xiao Zhang1
1Key Laboratory of Saline-alkali Vegetation Ecology Restoration, Ministry of Education, College of Life Science, Northeast Forestry University, Harbin 150040, China.
Abstract:
Triple negative breast cancer (TNBC) has poor prognosis due to lack of biomarker and therapeutic target. Emerging research has revealed long noncoding RNAs (lncRNAs) are involved in breast cancer progression, but their functions and regulatory mechanisms remain poorly understood, especially in TNBC. In this study, we performed lncRNA microarray analysis of five TNBC samples and their matched normal tissues, and discovered a number of differentially expressed lncRNAs. We identified an antisense lncRNA, HYOU1-AS, which is transcribed from the opposite strand of the hypoxia up-regulated 1 (HYOU1) gene, enriched in the nucleus and highly expressed in TNBC. HYOU1-AS knockdown could inhibit the proliferation and migration of the TNBC MDA-MB-231 cells, and reduce their xenograft tumor formation in nude mice. In mechanistic studies, we found that HYOU1-AS could promote the expression of HYOU1, a proliferative gene, through competitively binding to hnRNPA1, an RNA-binding protein, to relieve its post-transcriptional inhibition of the HYOU1 mRNA. Consistently, increased HYOU1 levels correlated with poor clinical outcomes of breast cancer patients based on our study of the TCGA database. Overall, our data indicated that the lncRNA HYOU1-AS promoted TNBC progression through upregulating HYOU1.
Insights
Triple negative breast cancer (TNBC) progression is promoted by the long noncoding RNA HYOU1-AS. This lncRNA upregulates the HYOU1 gene, impacting cell proliferation and migration, and is linked to poor patient outcomes.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Triple negative breast cancer (TNBC) presents a poor prognosis due to a lack of effective biomarkers and therapeutic targets.
- Long noncoding RNAs (lncRNAs) are increasingly implicated in cancer progression, but their specific roles in TNBC remain largely uncharacterized.
- Understanding lncRNA functions is crucial for developing novel therapeutic strategies against TNBC.
Purpose of the Study:
- To identify novel lncRNAs involved in TNBC pathogenesis.
- To elucidate the functional role and regulatory mechanism of a specific lncRNA, HYOU1-AS, in TNBC.
- To investigate the correlation between HYOU1-AS, its target gene HYOU1, and clinical outcomes in breast cancer patients.
Main Methods:
- lncRNA microarray analysis was performed on TNBC samples and matched normal tissues.
- HYOU1-AS expression and localization were analyzed in TNBC cells.
- Functional assays included HYOU1-AS knockdown in TNBC cells, xenograft tumor formation studies in nude mice, and mechanistic studies involving RNA-binding proteins.
- TCGA database analysis was used to correlate HYOU1 levels with patient outcomes.
Main Results:
- A novel antisense lncRNA, HYOU1-AS, was identified and found to be highly expressed in the nucleus of TNBC cells.
- Knockdown of HYOU1-AS inhibited TNBC cell proliferation, migration, and xenograft tumor growth.
- HYOU1-AS was shown to promote HYOU1 expression by competitively binding to hnRNPA1, thereby relieving post-transcriptional inhibition.
- Elevated HYOU1 levels correlated with poorer clinical outcomes in breast cancer patients.
Conclusions:
- The lncRNA HYOU1-AS acts as a driver of TNBC progression by upregulating the proliferative gene HYOU1.
- HYOU1-AS represents a potential diagnostic biomarker and therapeutic target for triple negative breast cancer.
- Targeting the HYOU1-AS/hnRNPA1/HYOU1 axis may offer a novel therapeutic strategy for TNBC treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Types of RNA
RNA Performs Diverse...
Experimental RNAi

